beta-lapachone has been researched along with Local Neoplasm Recurrence in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimokawa, M | 1 |
| Yoshizumi, T | 1 |
| Itoh, S | 1 |
| Iseda, N | 1 |
| Sakata, K | 1 |
| Yugawa, K | 1 |
| Toshima, T | 1 |
| Harada, N | 1 |
| Ikegami, T | 1 |
| Mori, M | 1 |
1 other study available for beta-lapachone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma.
Topics: Aged; Anoikis; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; G | 2020 |